Advancing the management of maternal, fetal, and neonatal infection through harnessing digital health innovations.

Infections occurring in the mother and neonate exert a substantial health burden worldwide. Optimising infection management is crucial for improving individual outcomes and reducing the incidence of antimicrobial resistance.

Digital health technologies, through their accessibility and scalability, hold promise in improving the quality of care across diverse health-care settings.

In settings with poor access to laboratory services, innovative uses of existing data, point-of-care diagnostics, and wearables could allow for better recognition of host responses during infection and antimicrobial optimisation.

The linkage and connectivity of information can support the coordinated delivery of care between health-care facilities and the community.

Continuous real-time monitoring of infection markers in the mother and neonate through biosensing can provide notable opportunities for intervention and improvements in care.

However, the development and implementation of these interventions should be respectful, prioritise safety, and emphasise sustainable, locally derived solutions. Addressing existing gender, economic, and health-care disparities will be essential for ensuring equitable implementation.